IL-6 drugs do work in COVID-19, says UK, as it plans NHS useNew data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus Share XIL-6 drugs do work in COVID-19, says UK, as it plans NHS usehttps://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/
Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trialRoche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances Share XRoche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trialhttps://pharmaphorum.com/news/roche-actemra-cuts-chances-of-covid-19/
Setback in COVID-19 effort as Roche’s Actemra fails in key trialRoche’s anti-inflammatory drug Actemra has failed in a phase 3 clinical trial that was testing to see if Share XSetback in COVID-19 effort as Roche’s Actemra fails in key trialhttps://pharmaphorum.com/news/setback-in-covid-19-effort-as-roches-actemra-fails-in-key-trial/
COVID-19 candidate Actemra helps Roche to solid first quarterRoche shrugged off the impact of the coronavirus pandemic in the first-quarter with good sales growth across its Share XCOVID-19 candidate Actemra helps Roche to solid first quarterhttps://pharmaphorum.com/news/covid-19-candidate-actemra-helps-roche-to-solid-first-quarter/
Roche begins phase 3 trial of Actemra in COVID-19 pneumoniaRoche is to begin a phase 3 trial of its Actemra/RoActemra as a treatment for patients hospitalised with Share XRoche begins phase 3 trial of Actemra in COVID-19 pneumoniahttps://pharmaphorum.com/news/roche-begins-phase-3-trial-of-actemra-in-covid-19-pneumonia/
